The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics), which provides non-dilutive support for biologics neurotherapeutics discovery and development, from lead optimization through phase I clinical testing, held a Q&A Webinar for potential applicants on Thursday, May 5th, 2022. Acting Program Director Dr. Mario Skiadopoulos provided an overview of the program and answered questions about the application process.
PAR-21-163 Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
PAR-20-122 Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
Next Receipt date for both BPN-Biologics Funding Opportunities is August 9th, 2022.
Webinar slides(pdf, 2060 KB)